Cargando…
Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers
We aimed at evaluating quantitative IgG response to BNT162b2 COVID-19 vaccine among health care workers (HCW), and exploring the role of demographic, clinical, and occupational factors as predictors of IgG levels. On May 2021, among 6687 HCW at the largest tertiary care University-Hospital of Northw...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955419/ https://www.ncbi.nlm.nih.gov/pubmed/35335105 http://dx.doi.org/10.3390/vaccines10030474 |
_version_ | 1784676331446861824 |
---|---|
author | Costa, Cristina Migliore, Enrica Galassi, Claudia Scozzari, Gitana Ciccone, Giovannino Coggiola, Maurizio Pira, Enrico Scarmozzino, Antonio La Valle, Giovanni Cassoni, Paola Cavallo, Rossana |
author_facet | Costa, Cristina Migliore, Enrica Galassi, Claudia Scozzari, Gitana Ciccone, Giovannino Coggiola, Maurizio Pira, Enrico Scarmozzino, Antonio La Valle, Giovanni Cassoni, Paola Cavallo, Rossana |
author_sort | Costa, Cristina |
collection | PubMed |
description | We aimed at evaluating quantitative IgG response to BNT162b2 COVID-19 vaccine among health care workers (HCW), and exploring the role of demographic, clinical, and occupational factors as predictors of IgG levels. On May 2021, among 6687 HCW at the largest tertiary care University-Hospital of Northwestern Italy, at a median of 15 weeks (Interquartile range-IQR 13.6–16.0) after second-dose, serological response was present in 99.8%. Seropositivity was >97% in all the subgroups, except those self-reporting immunodeficiency (94.9%). Overall, the median serological IgG value was 990 BAU/mL (IQR 551–1870), with most of subjects with previous SARS-CoV-2 infection or with shorter time lapse (2–8 weeks) between vaccination and serology with values in the highest quintile (>2080). At multivariable analysis, significant predictors of lower values were increasing age, male, current smoking, immunodeficiency, recent occupational contacts, and increasing time lapse from vaccination; conversely, previous infection and recent household contacts were significantly associated with higher IgG levels. Subjects with previous infection kept a very high level (around 2000 BAU/mL) up to 120 days. These results, besides supporting a high serological response up to 4–5 months, suggest predictive factors of faster decay of IgG levels that could be useful in tailoring vaccination strategies. |
format | Online Article Text |
id | pubmed-8955419 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89554192022-03-26 Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers Costa, Cristina Migliore, Enrica Galassi, Claudia Scozzari, Gitana Ciccone, Giovannino Coggiola, Maurizio Pira, Enrico Scarmozzino, Antonio La Valle, Giovanni Cassoni, Paola Cavallo, Rossana Vaccines (Basel) Article We aimed at evaluating quantitative IgG response to BNT162b2 COVID-19 vaccine among health care workers (HCW), and exploring the role of demographic, clinical, and occupational factors as predictors of IgG levels. On May 2021, among 6687 HCW at the largest tertiary care University-Hospital of Northwestern Italy, at a median of 15 weeks (Interquartile range-IQR 13.6–16.0) after second-dose, serological response was present in 99.8%. Seropositivity was >97% in all the subgroups, except those self-reporting immunodeficiency (94.9%). Overall, the median serological IgG value was 990 BAU/mL (IQR 551–1870), with most of subjects with previous SARS-CoV-2 infection or with shorter time lapse (2–8 weeks) between vaccination and serology with values in the highest quintile (>2080). At multivariable analysis, significant predictors of lower values were increasing age, male, current smoking, immunodeficiency, recent occupational contacts, and increasing time lapse from vaccination; conversely, previous infection and recent household contacts were significantly associated with higher IgG levels. Subjects with previous infection kept a very high level (around 2000 BAU/mL) up to 120 days. These results, besides supporting a high serological response up to 4–5 months, suggest predictive factors of faster decay of IgG levels that could be useful in tailoring vaccination strategies. MDPI 2022-03-18 /pmc/articles/PMC8955419/ /pubmed/35335105 http://dx.doi.org/10.3390/vaccines10030474 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Costa, Cristina Migliore, Enrica Galassi, Claudia Scozzari, Gitana Ciccone, Giovannino Coggiola, Maurizio Pira, Enrico Scarmozzino, Antonio La Valle, Giovanni Cassoni, Paola Cavallo, Rossana Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers |
title | Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers |
title_full | Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers |
title_fullStr | Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers |
title_full_unstemmed | Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers |
title_short | Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers |
title_sort | factors influencing level and persistence of anti sars-cov-2 igg after bnt162b2 vaccine: evidence from a large cohort of healthcare workers |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955419/ https://www.ncbi.nlm.nih.gov/pubmed/35335105 http://dx.doi.org/10.3390/vaccines10030474 |
work_keys_str_mv | AT costacristina factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT miglioreenrica factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT galassiclaudia factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT scozzarigitana factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT cicconegiovannino factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT coggiolamaurizio factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT piraenrico factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT scarmozzinoantonio factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT lavallegiovanni factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT cassonipaola factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT cavallorossana factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers AT factorsinfluencinglevelandpersistenceofantisarscov2iggafterbnt162b2vaccineevidencefromalargecohortofhealthcareworkers |